Our findings strongly suggest that eosinophils are activated in cGVHD, since we show that patients with cGVHD have higher levels of the eosinophilic activation markers CD9 and CD69 [38,39] than patients without GVHD. The gene discussed is CD69; the disease is graft versus host disease.